Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Stock market performance stories

Oct 30, 2026

AbbVie raises annual profit forecast on strong immunology drug sales

AbbVie raised its full-year profit forecast after beating third-quarter expectations, driven by strong demand for its newer immunology and neuroscience drugs as the company navigates the Humira patent cliff.

Oct 30, 2026·2 sources
00
Oct 28, 2026

Boston Scientific cuts outlook after cyberattack impacts operations

Boston Scientific lowered its full-year sales outlook to $5.45-5.55 billion from $5.44-5.64 billion and cut adjusted EPS guidance after a cyberattack disrupted operations, sending shares down.

Oct 28, 2026·2 sources
00

GSK shares fall after vaccine sales disappoint in Q3 results

GSK reported a drop in vaccine sales in its third quarter, sending shares down despite beating overall sales and profit expectations, as the UK drugmaker works to accelerate growth and prepare for patent expirations.

Oct 28, 2026·4 sources
00
Oct 26, 2026

Genmab's ovarian cancer drug cuts death risk 57% in late-stage trial

Genmab's experimental antibody-drug conjugate Rina-S reduced the risk of death by 57% compared to chemotherapy in patients with advanced ovarian cancer, according to phase 3 trial results presented at ESMO. The Danish drugmaker's shares surged over 12% on the news.

Oct 26, 2026·2 sources
00
Sep 2, 2026

Snowflake shares surge 22% on strong earnings despite bookings miss

Snowflake's stock jumped 22% in after-hours trading following second quarter fiscal 2027 results that beat expectations on revenue, profit, and guidance. However, one metric—bookings—fell short of analyst expectations, raising questions about future growth momentum.

Sep 2, 2026·3 sources
00
Aug 19, 2026

Unitree shares surge over 600% in Shanghai stock market debut

Unitree Robotics, the world's largest humanoid robot maker by sales, saw its shares jump more than 600% during its trading debut on Shanghai's STAR Market on Wednesday. The spectacular performance underscores China's rapid advancement in robotics technology.

Aug 19, 2026·16 sources
00

Unitree shares surge over 600% in Shanghai stock market debut

Unitree Robotics, the world's largest humanoid robot maker by sales, saw its shares jump more than 600% during its trading debut on Shanghai's STAR Market on Wednesday. The spectacular performance underscores China's rapid advancement in robotics technology.

Aug 19, 2026·6 sources
00

Unitree shares surge over 600% in Shanghai stock market debut

Unitree Robotics, the world's largest humanoid robot maker by sales, saw its shares jump more than 600% during its trading debut on Shanghai's STAR Market on Wednesday. The spectacular performance underscores China's rapid advancement in robotics technology.

Aug 19, 2026·12 sources
00
Aug 5, 2026

Uber stock falls 7% after weak profit forecast despite $10 billion robotaxi expansion plan

Uber Technologies shares dropped sharply after the company issued third-quarter earnings guidance below analyst expectations while announcing plans to invest over $10 billion in robotaxi expansion. The weak outlook comes amid uncertainty over its partnership with Waymo, though Uber maintains the Alphabet unit remains an important partner.

Aug 5, 2026·9 sources
00
Aug 4, 2026

Novo Nordisk shares slide despite beating quarterly estimates

Novo Nordisk reported quarterly results that beat expectations and raised guidance, but shares fell as investors remained concerned about the company's path to sustainable growth amid increasing competition in the obesity drug market.

Aug 4, 2026·2 sources
00
Jul 16, 2026

SpaceX stock falls below IPO price as Starship launch scrubbed

SpaceX shares dropped below their $135 IPO price after a last-second abort of the Starship test flight, with the stock having peaked above $200 following its record Nasdaq debut.

Jul 16, 2026·6 sources
00

Top claims

  • ▪AbbVie's neuroscience portfolio revenue grew 19% to $3.39 billion in the third quarter of 2026, driven by Botox Therapeutic and antipsychotic drug Vraylar
  • ▪AbbVie also raised its quarterly dividend alongside boosting its full-year 2026 profit outlook on October 30, 2026
  • ▪Rinvoq is indicated to treat a range of inflammatory joint, skin, and gastrointestinal conditions

People involved

Jon RonsonRobert F. Kennedy Jr.

Subtopics

Pharmaceutical Industry4China tech & industrial strategy3Corporate earnings3Humanoid Robots3Corporate strategy2Pharmaceutical earnings2Pharmaceutical patents2Autoimmune disease treatments1Autonomous Vehicles1Cancer & Oncology1Cancer treatment breakthroughs1Clinical trial endpoints1Clinical trials1Cloud data platforms1Corporate restructuring1Cybersecurity1Drug development1Earnings reports1Enterprise software1GPU performance1Healthcare cybersecurity1Healthcare industry1Immunology1Novo Nordisk1

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories